Enovis Corporation

31.41
-0.07 (-0.22%)
At close: Apr 16, 2025, 11:14 AM

Company Description

Enovis Corporation operates as a medical technology company worldwide.

It develops, manufactures, and distributes medical device products used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformities, traumatic events, and sports related injuries.

It offers rigid and soft orthopedic bracings, hot and cold therapy products, bone growth stimulators, vascular therapy systems and compression garments, therapeutic shoes and inserts, electrical stimulators used for pain management, and physical therapy products; and a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger.

Enovis Corporation sells its products through independent distributors, such as healthcare professionals, consumer retail stores, and pharmacies; and directly under the DJO brand.

The company was formerly known as Colfax Corporation.

Enovis Corporation is headquartered in Wilmington, Delaware.

Enovis Corporation
Enovis Corporation logo
Country United States
IPO Date May 8, 2008
Industry Industrial - Machinery
Sector Industrials
Employees 7,367
CEO Matthew L. Trerotola

Contact Details

Address:
2711 Centerville Road
Wilmington, Delaware
United States
Website https://www.enovis.com

Stock Details

Ticker Symbol ENOV
Exchange NYSE
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001420800
CUSIP Number 194014502
ISIN Number US1940145022
Employer ID 54-1887631
SIC Code 3842

Key Executives

Name Position
Matthew L. Trerotola Chief Executive Officer & Chairman
Phillip Benjamin Berry Senior Vice President & Chief Financial Officer
Brian P. Hanigan Secretary
Davide Visentin President of Enovis International Surgical
Katie Sweet Vice President of Corporate Communication
Louie Vogt Group President of Reconstructive
Terry D. Ross Group President Prevention & Recovery
Tim Czartoski President of U.S. Surgical and Global Product & Enabling Technologies

Latest SEC Filings

Date Type Title
Apr 11, 2025 4 Filing
Apr 11, 2025 DEFA14A Filing
Apr 11, 2025 DEF 14A Filing
Apr 02, 2025 8-K Current Report
Apr 01, 2025 4 Filing
Mar 14, 2025 8-K Current Report
Mar 11, 2025 4 Filing
Mar 11, 2025 4 Filing
Mar 11, 2025 4 Filing
Mar 11, 2025 4 Filing